Hims & Hers Health Inc. (NYSE:HIMS) shares are trading higher on Friday as traders continue to weigh fresh regulatory scrutiny against a generally risk-on tape. Here’s what investors need to know. Hims & Hers Health shares are trending higher. Why…
Johnson & Johnson (NYSE:JNJ) shares are edging higher on Friday as investors digest two major biotech pipeline moves. Johnson & Johnson stock is trading at elevated levels. Where are JNJ shares going? What Is Johnson & Johnson’s Latest Biotech Acquisition?…
FuelCell Energy Inc. (NASDAQ:FCEL) shares are trading lower on Friday as traders cool off after the recent AI-power enthusiasm tied to AI power demand. FuelCell Energy stock is taking a hit today. Why is FCEL stock falling? What Sparked FuelCell…
Circle Internet Group Inc. (NYSE:CRCL) stock fell Friday as Bitcoin (CRYPTO: BTC) declined and investors weighed regulatory uncertainty ahead of the stablecoin issuer’s second-quarter earnings report. The broader market was higher, with the Nasdaq gaining 0.98% and the S&P 500…
Amazon.com Inc. (NASDAQ:AMZN)‘s best earnings-day pop in years and a nearly $475 billion wipeout in Apple Inc. (NASDAQ:AAPL) market valuation pulled Wall Street in opposite directions Friday, leaving indexes searching for direction into midday as the AI trade split in…
Western Union (NYSE:WU) stock moved lower on Friday following the release of its quarterly earnings report on Thursday after the market close, alongside subsequent bearish analyst revisions. The company reported quarterly earnings of 31 cents per share, missing the analyst…
Moleculin Biotech Inc. (NASDAQ:MBRX) released updated blinded preliminary outcomes from Part A of its Phase 2/3 MIRACLE trial evaluating Annamycin with cytarabine for relapsed or refractory acute myeloid leukemia. Concurrently, the biopharmaceutical enterprise announced the pricing of a public stock…
Biotechnology firm Tiziana Life Sciences Ltd. (NASDAQ:TLSA) on Friday revealed promising quantitative PET imaging results from the third patient participating in its Phase 2 clinical trial. The ongoing study evaluates the company’s lead candidate, intranasal foralumab, designed as a treatment…
Dominion Energy Inc. (NYSE:D) reported better-than-expected second-quarter results on Friday and reaffirmed its full-year 2026 earnings guidance as electricity demand and data center growth continued to support its outlook. Adjusted earnings were 79 cents per share, topping the analyst consensus…
BioAge Labs Inc. (NASDAQ:BIOA) stock plunged Friday after disappointing Phase 3 cardiovascular trial results from Novo Nordisk A/S (NYSE:NVO) sparked concerns about the potential of NLRP3-targeting therapies. William Blair analyst Andy Hsieh said the results from Novo Nordisk’s ZEUS trial…